Stocktoria

DocGo Inc. DCGO

Nasdaq · stock · Services-Health Services · website · IPO 2020-10-15

DocGo Inc. (DCGO) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $322.2M at a -56.6% net margin.

Chart by TradingView
19/100
Stocktoria Quality Score · grade D
4/9
Piotroski F — financial health
-4.05
Altman Z″ — distress risk · distress
Dividend yield · no dividend

Quality score trend · recomputed for each fiscal year

Piotroski F /9
4 4 2 7 4 20212022202320242025
Altman Z″
6.75 5.55 4.05 5.44 -4.05 20212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$0.67 as of 2026-08-01 · -57.1% 1y
$0.52$1.5652-wk
Market cap USD$48M
Net margin 5y avg-7.4%
Return on equity 5y avg-19.1%
Beta1
Employees2,537

Analyst price target

$1.88 +180% vs last
· 4 analysts
target range $1.00 – $3.00

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Revenue trend · last 6y · up

How it ranks in Services · percentile among 982 companies

Piotroski Fstronger than 35%
Net marginstronger than 23%
Return on equitystronger than 10%
Revenue growthstronger than 3%

Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets0.391
Retained earnings / assets-0.847
EBIT / assets-0.82
Equity / liabilities1.579

Sector peers · similar-size Services companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
DCGODocGo Inc.4/9-4.05-47.7%
OMDAOmada Health, Inc.6/92.28+53.2%
TALKTalkspace, Inc.6/95.28112.2+22%
WGSGeneDx Holdings Corp.6/9-5.22+40%
SRTAStrata Critical Medical, Inc.4/96.5411.1+34.3%
VSEEVSEE HEALTH, INC.3/9-16.83+40.3%
EUDAEUDA Health Holdings Ltd5/9

All Services companies →

About DocGo Inc.

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, monitoring and care management, procedures, point-of-care tests, and screenings and coaching; event services, including on-site healthcare support at sporting events and concerts; virtual care management; and remote patient monitoring and chronic disease management services. The company serves municipalities, hospitals and health systems, states and communities, insurers, physician practices, health plans, and businesses and employees. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

FAQ

Is DCGO financially healthy?

DocGo Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does DCGO pay a dividend?

No, DocGo Inc. does not currently pay a dividend.

How profitable is DCGO?

In FY2025, DocGo Inc. had a net margin of -56.6% and a return on equity of -126.7%.

Is DCGO overvalued or undervalued?

DocGo Inc. trades at about 3.7× trailing earnings — below its 10-year norm (10-year range 27.2×–61.7×, median 29.4×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for DCGO?

The average Wall-Street price target for DocGo Inc. is $1.88, about 180.0% above the recent price, from 4 analysts.

Is DCGO a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on DocGo Inc.: a Piotroski F-score of 4/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.